These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18618305)

  • 1. Influence of alcohol on the release of tramadol from 24-h controlled-release formulations during in vitro dissolution experiments.
    Traynor MJ; Brown MB; Pannala A; Beck P; Martin GP
    Drug Dev Ind Pharm; 2008 Aug; 34(8):885-9. PubMed ID: 18618305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro - in vivo evaluation of a new oral dosage form of tramadol hydrochloride--controlled-release capsules filled with coated pellets.
    Szkutnik-Fiedler D; Balcerkiewicz M; Sawicki W; Grabowski T; Grześkowiak E; Mazgalski J; Urjasz H
    Acta Pol Pharm; 2014; 71(3):469-75. PubMed ID: 25265827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of processing variables on the mechanical and release properties of tramadol matrix tablets incorporating Cissus populnea gum as controlled release excipient.
    Adeleye OA; Femi-Oyewo MN; Odeniyi MA
    Polim Med; 2014; 44(4):209-20. PubMed ID: 25932902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the pharmacokinetics, clinical efficacy, and tolerability of once-daily tramadol tablets with normal release tramadol capsules.
    Bodalia B; McDonald CJ; Smith KJ; O'Brien C; Cousens L
    J Pain Symptom Manage; 2003 Feb; 25(2):142-9. PubMed ID: 12590030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous twin screw melt granulation of glyceryl behenate: Development of controlled release tramadol hydrochloride tablets for improved safety.
    Keen JM; Foley CJ; Hughey JR; Bennett RC; Jannin V; Rosiaux Y; Marchaud D; McGinity JW
    Int J Pharm; 2015 Jun; 487(1-2):72-80. PubMed ID: 25839417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of extended-release versus conventional tramadol/acetaminophen fixed-dose combination tablets: an open-label, 2-treatment, multiple-dose, randomized-sequence crossover study in healthy korean male volunteers.
    Yi S; Chung YJ; Kim TE; Shin HS; Yoon SH; Cho JY; Jang IJ; Shin SG; Yu KS
    Clin Ther; 2011 Jun; 33(6):728-37. PubMed ID: 21704237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and in vitro-in vivo relationship of controlled-release microparticles loaded with tramadol hydrochloride.
    Naeem Aamir M; Ahmad M; Akhtar N; Murtaza G; Khan SA; Shahiq-uz-Zaman ; Nokhodchi A
    Int J Pharm; 2011 Apr; 407(1-2):38-43. PubMed ID: 21241789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic properties of tramadol sustained release capsules. 2nd communication: investigation of relative bioavailability and food interaction.
    Raber M; Schulz HU; Schürer M; Bias-Imhoff U; Momberger H
    Arzneimittelforschung; 1999 Jul; 49(7):588-93. PubMed ID: 10442206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic properties of tramadol sustained release capsules. 1st communication: investigation of dose linearity.
    Schulz HU; Raber M; Schürer M; Amschler S; Momberger H
    Arzneimittelforschung; 1999 Jul; 49(7):582-7. PubMed ID: 10442205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biopharmaceutical evaluation of new slow release tablets obtained by hot tableting of coated pellets with tramadol hydrochloride.
    Szkutnik-Fiedler D; Sawicki W; Balcerkiewicz M; Mazgalski J; Grabowski T; Grześkowiak E
    Acta Pol Pharm; 2014; 71(5):813-20. PubMed ID: 25362810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic properties of tramadol sustained release capsules. 3rd communication: investigation of relative bioavailability under steady state conditions.
    Raber M; Schulz HU; Schürer M; Krupp S; Momberger H
    Arzneimittelforschung; 1999 Jul; 49(7):594-8. PubMed ID: 10442207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended-release Tramadol (ULTRAM ER): a pharmacotherapeutic, pharmacokinetic, and pharmacodynamic focus on effectiveness and safety in patients with chronic/persistent pain.
    Barkin RL
    Am J Ther; 2008; 15(2):157-66. PubMed ID: 18356636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative bioavailability between two Tramadol once-daily oral formulations.
    Hernandez-Lopez C; Martinez-Farnos L; Karhu D; Perez-Campos T; Rovira S; Encina G
    Methods Find Exp Clin Pharmacol; 2006; 28(6):373-8. PubMed ID: 16894407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single- and multiple-dose bioequivalence of two once-daily tramadol formulations using stereospecific analysis of tramadol and its demethylated (M1 and M5) metabolites.
    Eradiri O; Sista S; Lai JC; Nguyen OH; Silverstone PH
    Curr Med Res Opin; 2007 Jul; 23(7):1593-604. PubMed ID: 17559753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and biopharmaceutical evaluation of extended release formulation of tramadol hydrochloride based on osmotic technology.
    Kumar P; Singh S; Mishra B
    Acta Pharm; 2009 Mar; 59(1):15-30. PubMed ID: 19304555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative pharmacokinetics of a once-daily tramadol extended-release tablet and an immediate-release reference product following single-dose and multiple-dose administration.
    Karhu D; Fradette C; Potgieter MA; Ferreira MM; Terblanché J
    J Clin Pharmacol; 2010 May; 50(5):544-53. PubMed ID: 20051587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tramadol sustained-release capsules.
    Keating GM
    Drugs; 2006; 66(2):223-30. PubMed ID: 16451094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of ethanol on the bioavailability of oxymorphone extended-release tablets and oxymorphone crush-resistant extended-release tablets.
    Fiske WD; Jobes J; Xiang Q; Chang SC; Benedek IH
    J Pain; 2012 Jan; 13(1):90-9. PubMed ID: 22208805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-Dose Pharmacokinetic Study of Tramadol Extended-Release Tablets in Children and Adolescents.
    Vandenbossche J; Van Peer A; Richards H
    Clin Pharmacol Drug Dev; 2016 Sep; 5(5):343-53. PubMed ID: 27138295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Alcohol-Induced Dose Dumping with a Hydrocodone Bitartrate Extended-Release Tablet Formulated with CIMA(®) Abuse Deterrence Technology.
    Darwish M; Bond M; Yang R; Tracewell W; Robertson P
    Clin Drug Investig; 2015 Oct; 35(10):645-52. PubMed ID: 26369654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.